Lisbon
Portugal
National Institute of Health Doutor Ricardo Jorge
COVID-19, vaccine effectiveness, multicentre study, test-negative design, Europe, SARS-CoV-2
COVID-19, SARS-CoV-2, Vaccine effectiveness, Primary care, Case-control study, Test-negative design, Multi-country study